APAC Contraceptives Market Analysis

$3,500.00$7,500.00

  • Type: Common Disease Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 4992

  • Format: PPT, PDF

APAC Contraceptives Market Analysis: Segmented by Drug Type, Medical Devices, End-Users, Country – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 4992 Categories: ,

Report Description of the APAC Contraceptives Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Contraceptives  Market  Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Contraceptives  Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Contraceptives Market Analysis Executive Summary

Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy.

Market Size and Key Findings

The APAC Contraceptives Market Analysis size stood at around USD 5.74 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 6.95% during the forecast period.

The Asia-Pacific contraceptive market is expected to reach at a CAGR of 6.95% during the forecast period 2020-2028.

Market Dynamics

Market Growth Drivers Analysis

The major factors attributing to the growth of the Asia-Pacific contraceptive drugs and devices market include the necessity to avoid unwanted pregnancies and their complications. The need to avoid unwanted pregnancies, especially in teenage women, is one of the major drivers for this market. It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population in the region.

Market Restraints

In spite of all these advantages, factors such as lack of acceptance faced by contraceptives are impeding the market growth. Socio-cultural opposition for the use of contraceptives in countries having conservative populations is a major restraining factor. Moreover, lack of accessibility and misperceptions about the use of contraceptives are some of the challenges faced by the contraceptive industry.

COVID-19 impact on “APAC Contraceptives Market”

The COVID-19 epidemic has impacted negatively on healthcare services and technology around the world. It disrupted the demand and supply chain. Due to this pandemic, proper healthcare services and facilities were not available, as supply chains get disrupted, there were limited availability of contraceptives with product shortage & stock outs, lack of trained workers, and due to lack of personal protective equipment to provide safe services, due to the fear of Covid-19.

Competitive Landscape

Key Players

The Asia-Pacific contraceptive market has been segregated into various categories based on age groups, education, drugs & devices and end users. Companies such as Cooper Surgical, Inc., Merck & Co., Inc., Church & Dwight Co., Inc., Teva Pharmaceutical Industries, Ltd., Apothecus Pharmaceutical Corporation, Pregna, Pfizer, Inc., Bayer AG, Melbea, SMB Corporation, Reckitt Benckiser PLC, Mayer Laboratories, Inc., Ocon Medical, Ltd., Okamoto Industries, Inc., Afaxys, Inc., Allergan, Inc. and Agile Therapeutics have been the leading manufacturers of contraceptives.

Products in Pipeline

  • In August 2018, Lupin Pharmaceuticals announced the launch of Drospirenone, Ethinyl Estradiol, and levomefolate Calcium tablets contraceptive drugs in the U.S.
  • In May 2018, Aurobindo Pharma launched MILI and TRI-MILI oral contraceptive tablets for use in women to avoid conception.
  • In April 2018, Mylan N.V., launched generic YAZ oral contraceptive drug for use by women to avoid unintentional pregnancy.

Notable Recent Deals

  • In November 2018, The population Control Council, Los Angeles Bio Medical Research Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and University of Washington School of Medicine launched first clinical study to test the efficacy and safety of a gel to be used by men for the prevention of unintended pregnancy.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

More than 218 million women living in developing countries do not want to become pregnant but do not use effective contraceptive methods. For some of them, access to contraception is limited; for others, available methods are not acceptable or affordable. The goal of the Contraceptive Technology Innovation (CTI) Initiative is to develop new and strategically important contraceptives, through a strong focus on global partnerships, that ensures wide access to quality, affordable and acceptable products for those most in need. The CTI Initiative, a project funded by the Bill & Melinda Gates Foundation, is in Phase 2 of implementation. Overall, the CTI Initiative aims to develop new contraceptive products that are safe, effective, low-cost, easy to use and appealing to women in greatest need.

Investment in contraceptive research to identify new products for women has been limited in the pharmaceutical industry relative to investment in drug development for other indications. Pharmaceutical R&D for male contraception was active in the 1990’s but was abandoned over a decade ago. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has supported a contraceptive development program since 1969. Through a variety of programs including research grants and contracts, NICHD has developed a pipeline of new targets/products for male and female contraception. A number of lead candidates are under evaluation in the NICHD Contraceptive Clinical Trials Network (CCTN)

1. Report Description of the APAC Contraceptives Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Contraceptives Market Analysis Executive Summary
2.1 APAC Contraceptives Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Contraceptives Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increasing incidence of STDs
3.1.2 Avoid unwanted pregnancies
3.2 Market Restraints Analysis
3.2.1 Lack of acceptance faced by contraceptives
3.2.2 Socio-cultural opposition
3.3 Covid-19 Market Impact Analysis
4. APAC Contraceptives Market Segmentation
4.1 By Drug Type:
4.1.1 Contraceptive Pills
4.1.2 Topical Contraceptives
4.1.3 Contraceptive Injectable
4.1.4 Others (Contraceptive Gels, Jellies, and Creams)
4.2 By Medical Devices:
4.2.1 Male Contraceptive Devices
4.2.2 Female Contraceptive Devices
4.2.3 Contraceptive Sponges
4.2.4 Contraceptive Diaphragms
4.2.5 Sub dermal Contraceptive Implants
4.2.6 Contraceptive Patches
4.2.7 Non-Surgical Permanent Contraceptive Devices
4.3 By End-Users:
4.3.1 Hospitals
4.3.2 Home Care
4.3.3 Clinics
4.3.4 Ambulatory Surgical Centres
4.4 By Country:
4.4.1 India
4.4.2 China
4.4.3 Japan
4.4.4 Australia
4.4.5 New Zealand
4.4.6 ASEAN Countries
4.4.7 Rest of APAC
5. APAC Contraceptives Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Contraceptives Market
6.4 Notable recent deals in Contraceptives Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Allergan Inc. Company overview
Product & Services, Strategies & Financials
7.2 Bayer AG Company overview
Product & Services, Strategies & Financials
7.3 Pfizer Inc. Company overview
Product & Services, Strategies & Financials
7.4 Church & Dwight Co., Inc. Company overview
Product & Services, Strategies & Financials
7.5 Cooper Surgical Inc. Company overview
Product & Services, Strategies & Financials
7.6 Merck & Co., Inc. Company overview
Product & Services, Strategies & Financials
7.7 Teva Pharmaceutical Industries Ltd. company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Contraceptives market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Contraceptives Market Analysis Segmentation

By Drug Type:

By  drug  type,  the  contraceptive  pills  industry  is  the largest  within  the  segment  owing  to  the widespread  use  of  oral  pills  by  women.  This  is  mainly  because  they  are  proven  to  be  highly effective  up  to  99%  in  preventing  pregnancy. The  condoms  are  the  most  commonly  used contraceptive  devices  accounting  for  around  two-thirds  of  the  contraceptives  market  share  in 2016. However, IUDs are gaining momentum and are expected to grow at a faster pace during the analysis period.

By Medical Devices:

Based on Medical Devices, the market is segmented condoms, intrauterine product (IUDs), vaginal rings, implants, patches, diaphragms, emergency contraceptives, sponges, and others. The condoms segment dominated the market in 2020 and intrauterine product (IUDs) segment is expected to be the fastest growing during the forecast period. Further, the condoms segment has been bifurcated into female condoms and male condoms. Similarly, the intrauterine product (IUDs) segment is bifurcated into hormonal IUDs and copper IUDs.

By End-Users:

Based on end user, the market is segmented into home care, and hospitals and clinics. The home care segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period.  

By Country:

The contraceptives market of Asia Pacific includes countries such as China, Japan, India, Australia, South Korea and the rest of Asia Pacific. This region accounted for over fastest growing region of the global contraceptives market in 2020 owing to the rising awareness for unwanted pregnancies, increasing prevalence of STIs and the rapid rise in population in the region. Like any other country across the world, China is facing similar problems regarding sexually transmitted diseases. China has witnessed a rising epidemic of sexually transmitted infections (STIs), including HIV. Female sex workers (FSWs) and their clients, drug users, men who have sex with men (MSM), and migrant workers are groups having high risk of getting a STI. There are an around 2.8 to 4.5 million FSWs; 21.9 to 37.4 million clients of FSWs; 2 to 10 million MSM and 130 million migrant workers in China. Thus, this is likely to increase the demand for condoms in the country. Increasing awareness about sexually transmitted diseases is the major factor driving the growth of the APAC contraceptives market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements